About Us
Science Programs
Pipeline
Clinical Trials
Careers
cONTACT
Resources
Corporate Presentation
Posters, PRESENTATIONS & Publications
MEDIA
Events
News & press releases
Investors
Overview
Stock Information
Analyst Coverage
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Financials & SEC FILINGS
Sec Filings
Quarterly Results
cORPORATE GOVERNANCE
Management Team
Board of Directors
Committee Composition
Governance Documents
News & Press Releases
Get up to speed with Rain!
Filter by year...
2022
2021
2020
2019
2018
Reset Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November
18
,
2022
Rain Therapeutics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
Download PDf
November
17
,
2022
Rain Therapeutics Announces an Oral Presentation at the Connective Tissue Oncology Society Annual Meeting
Download PDf
November
14
,
2022
Rain Therapeutics to Participate in H.C. Wainwright’s 3rd Annual Precision Oncology Virtual Conference
Download PDf
November
10
,
2022
Rain Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
Download PDf
November
4
,
2022
Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
Download PDf
November
4
,
2022
Rain Therapeutics Provides Interim Analysis of Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)
Download PDf
October
27
,
2022
Rain Therapeutics to Report Third Quarter 2022 Financial Results and Highlights of Recent Progress on November 10, 2022
Download PDf
October
26
,
2022
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
Download PDf
August
31
,
2022
Rain Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference
Download PDf
August
4
,
2022
Rain Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
Download PDf
Previous
#
Next
